SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Donald Gravenor who wrote (928)6/29/2000 1:37:00 PM
From: Ian@SI  Read Replies (1) of 1321
 
don,

Those of us who're long, think that it's just beginning its move. Historically, emerging biotechs show their best price gains in the 2 years leading into and the 2 years after the first Q of profitability.

For QLTI, that first Q of profitability will be the end of this year.

I can appreciate that those of you who're short or regret not buying 50 points ago, would like to think that it's "...getting a bit ahead of itself."

Check in 6 months from now and let us all know if you've figured out the answer to your question.

Ian.

QLT Photother. (QLTI) 68 1/2 + 1/4: Lehman Brothers initiates coverage with a BUY rating and price target of $100.
(RTQ at 13:34: 71 up 2 3/4)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News